|
HS Code |
899064 |
| Generic Name | Benzathine Benzylpenicillin |
| Other Names | Benzathine Penicillin G |
| Drug Class | Beta-lactam Antibiotic |
| Route Of Administration | Intramuscular injection |
| Appearance | White crystalline powder |
| Mechanism Of Action | Inhibits bacterial cell wall synthesis |
| Spectrum Of Activity | Primarily Gram-positive bacteria |
| Half Life | 2 to 4 weeks (depot effect) |
| Indications | Treatment of syphilis, rheumatic fever prophylaxis, streptococcal infections |
| Contraindications | Penicillin allergy |
| Pregnancy Category | Category B |
| Common Side Effects | Hypersensitivity reactions, injection site pain |
| Storage Conditions | Store below 25°C, protect from light |
| Formulation | Powder for injection |
| Atc Code | J01CE08 |
As an accredited Benzathine Benzylpenicillin factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging for Benzathine Benzylpenicillin includes a white 1,200,000 IU vial, labeled with blue text and sealed with a rubber stopper. |
| Shipping | Benzathine Benzylpenicillin should be shipped in tightly sealed containers, protected from light and moisture. Transport at controlled room temperature (15–25°C), avoiding extreme heat or freezing. Ensure packaging prevents breakage and contamination. Clearly label the package with chemical identification, hazard warnings, and handling instructions, complying with local and international shipping regulations for pharmaceuticals. |
| Storage | Benzathine Benzylpenicillin should be stored at a temperature between 2°C and 8°C (refrigerated), protected from light, and kept in its original container. It should not be frozen. Keep out of reach of children. Proper storage ensures the stability and efficacy of the antibiotic. Always check expiration dates and do not use if there are visible changes in the product’s appearance. |
|
Purity 98%: Benzathine Benzylpenicillin with purity 98% is used in intramuscular antibiotic therapy, where it ensures reliable eradication of Streptococcus pyogenes. Molecular Weight 940.15 g/mol: Benzathine Benzylpenicillin with molecular weight 940.15 g/mol is used in the formulation of long-acting infection treatments, where it offers sustained antibacterial efficacy. Stability Temperature 25°C: Benzathine Benzylpenicillin with stability temperature of 25°C is used in rural healthcare supply chains, where it maintains potency during extended storage. Particle Size <10 μm: Benzathine Benzylpenicillin with particle size less than 10 μm is used in injectable suspensions, where it enables consistent bioavailability and depot formation. Melting Point 164°C: Benzathine Benzylpenicillin with melting point 164°C is used in high-stability drug preparations, where it reduces degradation risk under standard conditions. Solubility in Water <1 mg/mL: Benzathine Benzylpenicillin with solubility in water less than 1 mg/mL is used in depot injection formulations, where it provides extended therapeutic effect by slow release. Viscosity Grade 150 cP: Benzathine Benzylpenicillin with viscosity grade 150 cP is used in sustained-release parenteral formulations, where it facilitates uniform suspension for reliable dosing. pH Stability Range 5.5–7.0: Benzathine Benzylpenicillin with pH stability range of 5.5–7.0 is used in intramuscular preparations, where it minimizes risk of local tissue irritation. |
Competitive Benzathine Benzylpenicillin prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Benzathine benzylpenicillin usually comes into focus when healthcare professionals dig deep into infection control. I’ve seen this penicillin-based antibiotic become a trusted ally in fighting certain stubborn infections. It’s not the go-to treatment for every bug, but for ailments like syphilis, rheumatic fever, or strep throat, it offers some unique advantages. This compound is also known as penicillin G benzathine and operates with a key difference compared to regular penicillin: it provides a slow, sustained release. You get a single injection that keeps the medication working in the body much longer. That’s an enormous benefit for patients who struggle to keep up with daily pills or need protection over several weeks.
People with backgrounds in nursing or pharmacy notice that single-dose regimens cut down clinic visits. It also limits the chances someone forgets a dose at home. Benzathine benzylpenicillin gives an answer to both issues. I remember times patients would fall off course with oral meds — either from confusion, busy schedules, or because it just got lost in the shuffle of daily life. They’d come back not fully treated, which let infections hang around and sometimes become dangerous. This injection does away with many of those worries. Doctors get peace of mind, and so do patients, because there’s less room for error.
Benzathine benzylpenicillin shows up in 1.2 million IU and 2.4 million IU vials. You’ll find it as a white powder, which gets mixed with sterile water before an injection. This detail means a skilled hand needs to prepare it properly, double-checking the dosage to match each patient’s weight, age, and diagnosis. Clinics and hospitals keep it on hand for both children and adults. Unlike oral penicillins, you’re delivering medication directly into muscle, usually in the hip or upper outer quadrant of the buttock. That’s pain, sure, but some would say it’s easier than trying to remember pills three times a day for a week.
A nurse I worked with described the experience of administering benzathine benzylpenicillin as different than quick injections. This shot goes in slow, as the thick solution can cause a real burning sensation. Not pleasant, but necessary. Folks on the receiving end often ask why the medicine feels so thick — that’s the benzathine salt, which slows down how quickly the body absorbs the drug. It lingers, targets bacteria, and means fewer injections over time.
The pharmacy world keeps strict regulations on this medication. Not everyone can walk into a store and pick it up; a prescription is always a must. As more attention focused on antibiotic stewardship in recent years, hospital committees began to watch for proper use. The long-acting design is helpful, but overuse or incorrect prescribing could lead to resistance. Most clinicians I know take blood tests or swabs before reaching for this option, making sure the bacteria involved can be stopped with a penicillin and that patients aren’t allergic.
On the ground, benzathine benzylpenicillin steps in where adherence to daily medication seems tough or when guidelines demand a one-time dose. The classic conditions — syphilis, as recommended by the CDC and WHO, and prevention of rheumatic fever — bring particular patients into the clinic. One dose clears up early syphilis, or, in other protocols, a short series takes the place of weeks of oral therapy. For kids with recurring strep infections, repeated shots every three or four weeks help prevent rheumatic heart disease. Countries with few resources count on this medicine for exactly that reason.
Let’s talk safety: allergies to penicillin remain a challenge. The medical field has gotten better at distinguishing true allergies from reports of childhood rashes or vague reactions. Lives depend on catching severe allergies, though, so healthcare staff never skip that all-important questioning before giving the shot. Stocking epinephrine and watching the patient for a bit afterward becomes routine. I often see the hesitancy in the eyes of patients who've heard horror stories about penicillin reactions. Being upfront about possible side effects and watching for symptoms builds a key trust.
From the pharmacist’s point of view, the focus stays on storage and preparation. The injection powder demands a cool, dry place until it gets mixed. The final solution passes through a thick needle. Anyone drawing up the dose verifies the correct vial strength and double-checks the expiry. Sending out the wrong dose or mixing errors doesn’t just delay care — it can cause real harm.
With every new antibiotic on the market, you see more options for treating infections. Some promise rapid results, others advertise oral convenience. What sets benzathine benzylpenicillin apart isn’t the strength or the class — it’s the timeline. The medicine keeps active in the body far beyond typical penicillins. If you’ve watched patients struggle to manage daily pills, you know how tough life can get. Routines fall apart during holidays, busy school periods, or simple forgetfulness. The long-acting form makes it possible to keep things simple and effective.
Comparing it to amoxicillin or oral penicillin, which need several doses daily, the long action matters. It saves costs associated with missed appointments, reduces hospital stays, and helps public health by lowering untreated infection rates. In countries where rural communities stretch far and travel is difficult, this shot offers one of the simplest ways to guarantee real coverage.
Few antibiotics can match its ability to curb rheumatic fever or interrupt syphilis transmission with so little follow-up. I’ve read stories from colleagues who spent months in low-resource settings — they see firsthand that consistent delivery makes a bigger impact than the latest pricey pill on the shelf. A single injection does more than treat; it helps break cycles of disease and poverty tied to chronic illness.
Benzathine benzylpenicillin has significant benefits, but not every aspect is rosy. The pain of the shot leads some to dread appointments. Complaints about the injection site, bruising, or mild fever are common. For children, the experience can be traumatic enough to spark real anxiety. Some clinics try to minimize discomfort with numbing sprays or by encouraging distraction techniques. Others offer short post-injection observation and a small treat for kids. Every bit helps, but I remember wishing for easier ways to deliver this essential therapy — a pill with the same longevity would change lives. Until that becomes reality, providers focus on training, empathy, and reassurance.
Another hurdle comes from supply. During global drug shortages, access to benzathine benzylpenicillin gets thrown into question. Healthcare providers scramble for alternatives, which often don’t work as well or require more complicated dosing. Public health authorities need to plan stock management at national and local levels, especially in places where outbreaks risk many lives. Streamlining procurement, increasing local manufacturing, and international cooperation rank high on proposed solutions. From experience, strong advocacy from clinicians and patient groups moves the needle more than quiet complaints in mailrooms or offices.
Safe use also requires vigilance. Overprescribing any antibiotic encourages resistance — a reality that haunts every healthcare system. Education on best practice prescribing, reliable allergy screening, and promoting guidelines that balance urgency with safety must remain priorities. Conversations about antibiotic stewardship fill conference halls and training programs. In my experience, clear communication between pharmacists, doctors, and patients prevents more problems than any high-tech monitoring solution.
Infectious disease experts track the impact of benzathine benzylpenicillin across continents. Some countries launched massive campaigns to treat and prevent rheumatic heart disease with regular injections, slashing new cases among children. The success stories from Cuba, Australia, and Pacific Island nations show that when local healthcare workers train with a focus on both technique and patient rapport, compliance rates soar and outcomes improve.
The World Health Organization and other large bodies keep benzathine benzylpenicillin squarely in their essential medicines lists, because they recognize its special value in community-wide disease control. That status comes from years of real-world evidence rather than sales pitches or short-term studies. The medicine helped roll back epidemics of syphilis in urban and rural settings alike. In my fieldwork, communities with robust access experienced not just lower disease rates, but also fewer tragedies tied to fetal and newborn infections. The reduction in congenital syphilis keeps families together and helps avoid expensive treatments years down the line.
One lesson stands out: no matter the setting, education and respect for patient concerns underpin successful use. When local leaders share stories of friends or relatives saved by a single injection, trust in the clinic grows. Patients less often miss appointments and show up more open to advice about symptoms, aftercare, or allergy checks. I’ve witnessed the power of a shared experience to change minds more than graphs or charts ever could.
Looking at gaps in access, several approaches come up. Governments and nonprofits can prioritize training for nurses and pharmacists in proper injection technique and allergy safety. Grants aimed at building up cold-chain storage keep vials safe in hot climates or remote clinics. Community outreach programs, especially in places where past histories of medical mistrust weigh heavy, can educate on the benefits and expectations of receiving the medicine.
Some researchers work on new formulations that might offer the same long-acting effect with less pain or simpler storage. Until those reach market, supply-chain professionals suggest creating buffer stocks, clear ordering systems, and regional collaborations to buffer against shortages. Doctors in high-need regions ask for support not just for medicine costs but for the support infrastructure — transportation, monitoring, education, and post-injection care. Often, pharmaceutical companies can help by offering transparent pricing or supporting programs in low-income regions, though the focus must always stay on patient needs over profits.
I’ve met clinic managers who built easy “call-back” systems or text reminders that let families know when the next injection comes due, boosting adherence and making the process less intimidating. Simple solutions sometimes have the most lasting effect. Building partnerships between central hospitals and satellite clinics ensures consistent dosing and helps track long-term outcomes. These lessons carry over to other medicines as well, showing that strong community health foundations amplify the value of essential drugs like benzathine benzylpenicillin.
Much of the conversation today in global public health focuses on equity and responsible care. Benzathine benzylpenicillin reminds us that older medicines, when managed well, remain indispensable. Shortages raise ethical questions; a mother in one country might receive timely, high-quality care, while another just as deserving misses out. Solutions demand both broad-scope policy from government and boots-on-the-ground care coordination.
Doctors, pharmacists, and nurses look for the right balance between cost, availability, and real-world effectiveness. That means reviewing each patient individually. Guidelines suggest a path, but patient stories and local context should shape the final call. Improving safety comes back to basics: good training, seamless teamwork, honest patient communication. There’s never room to cut corners where allergy rates run high or staff feel overwhelmed.
Many programs now include both detailed informed consent and clear documentation, so families walk into a clinic understanding both risks and benefits. That transparency improves outcomes and builds reputation. In my clinics, I keep an eye on feedback — not just from patients but from the nursing staff and support workers who see the full picture. Regular case reviews catch any problems early and create a culture of improvement. Those habits raise the standard of care, not just for benzathine benzylpenicillin but across all therapies.
Infection control won’t rest on new products alone. Benzathine benzylpenicillin stands as evidence that innovation comes from using established tools smartly, adapting protocols over time, and listening closely to patients. The fight against re-emerging diseases shows no signs of ending, and access to reliable, effective therapy forms the bedrock of public health in any setting. Where the medicine meets challenges — painful injection, supply hiccups, or allergy fears — new generations of health workers rise to address the need.
For the foreseeable future, I see benzathine benzylpenicillin holding its place in hospitals and field clinics. Its lessons go beyond antibiotics. They remind every practitioner that treatment works best as a partnership, with clear communication and structures in place for support. Investment in health system readiness, smart supply chains, and frontline worker education protects communities not just from today’s threats, but those on the horizon. I’d encourage anyone with a role in policy, supply, or direct patient care to keep championing medicines like this — not as relics, but as lifelines with stories and proven benefits in every dose.